๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients

โœ Scribed by G. Licata; R. Scaglione; A. Ganguzza; G. Parrinello; R. Costa; G. Merlino; S. Corrao; P. Amato

Publisher
Springer
Year
1993
Tongue
English
Weight
510 KB
Volume
45
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of the renal effects of dilev
Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension
โœ T. Baba; S. Murabayashi; T. Tomiyama; K. Takebe ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 339 KB

The effects of 6 weeks of treatment with dilevalol 100 mg once daily, or carteolol 10 mg once daily, on renal blood flow (RBF), glomerular filtration rate (GFR) and total renal vascular resistance (TRR) were studied in 10 patients with mild-to-moderate essential hypertension in a randomised cross-ov

Antihypertensive efficacy and effects of
Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: Randomized controlled trial versus hydrochlorothiazide
โœ Rosario Scaglione; Angelo Indovina; Gaspare Parrinello; Rosario Lipari; Luigi Gi ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer US ๐ŸŒ English โš– 519 KB

In this study antihypertensive efficacy, safety, and the effects of short-term nitrendipine administration on central and renal hemodynamics were evaluated in mild to moderate hypertensives. Our final goal was to ascertain whether the reduction in blood pressure induced by nitrendipine treatment was

Comparison of the antihypertensive and r
Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment
โœ F. Fallo; M. Gregianin; F. Bui; C. Macrรฌ; P. Folino; F. Mantero ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 295 KB

The antihypertensive and renal haemodynamic effects of 5 mg/day tertatolol (T), a new nonselective and long-acting beta-adrenoceptor blocker, and 80 mg/day nadolol (N) in hypertensive patients with mild renal impairment have been compared in a randomized double-blind trial. Before and after 30 days